Does insulin resistance cause ovulatory dysfunction and lower corpus luteum progesterone output?

Insulin resistance acts as a significant disruptor of reproductive health, primarily by interfering with the delicate hormonal signaling required for both ovulation and subsequent progesterone production.

Clinical and mechanistic evidence for ovulatory dysfunction

Insulin resistance (IR) is a primary driver of ovulatory failure, particularly through the mechanism of compensatory hyperinsulinemia.

• The Insulin-Androgen Axis: While muscle and fat tissues may become resistant to insulin, the ovarian theca cells remain hypersensitive to its steroidogenic actions. High circulating insulin levels bind to ovarian receptors, upregulating enzymes such as CYP17. This triggers the overproduction of androgens (testosterone and androstenedione), which causes follicular arrest and oligoanovulation.
• Prevalence and Causal Data: Research indicates that IR is present in up to 95.4% of anovulatory subjects compared to 20.5% of infertile but ovulatory women. Experimental models confirm this link; for example, deleting insulin receptors specifically in ovarian theca cells prevents the androgen excess and ovulatory failure that typically follows a high-fat diet.
• Metabolic Markers: Markers associated with IR, such as elevated triglycerides and low HDL, are strongly correlated with menstrual irregularity and sporadic anovulatory cycles (p < 0.05 in multiple cohorts).

Impact on corpus luteum and progesterone output

The relationship between insulin resistance and the corpus luteum (CL) is bidirectional but clinically indicates that metabolic dysfunction can impair progesterone output.

• Steroidogenic Inhibition: Hyperinsulinemia may antagonize the luteinizing hormone (LH)-driven induction of Steroidogenic Acute Regulatory protein (StAR). Because StAR is the rate-limiting step for progesterone synthesis, its suppression directly reduces the CL's output.
• Cellular Signaling: In granulosa-lutein cells, insulin resistance—often exacerbated by metabolic markers like chemerin—impairs AKT signaling and glucose uptake. This metabolic stress activates AMP-activated protein kinase (AMPK), which further inhibits the enzymes necessary for steroidogenesis.
• Clinical Observations: In conditions like PCOS, elevated insulin levels are frequently correlated with suppressed luteal progesterone. Conversely, improving insulin sensitivity with metformin has been shown in some studies to restore or enhance progesterone levels during the luteal phase.

Bottom line

Insulin resistance is a well-supported cause of ovulatory dysfunction via hyperinsulinemia-driven androgen excess. It also plausibly impairs corpus luteum function by disrupting the cellular signaling and enzymatic pathways (specifically StAR) required for robust progesterone production.